Capsule with steeping chamber

Information

  • Patent Grant
  • 10336531
  • Patent Number
    10,336,531
  • Date Filed
    Friday, March 20, 2015
    9 years ago
  • Date Issued
    Tuesday, July 2, 2019
    4 years ago
Abstract
A capsule is provided for use in a machine for preparing a consumable product from capsules. The capsule includes a body that defines an interior space with an opening. A cover is disposed over the opening and is adapted to shrink sufficiently when pierced by the injection system to allow pressure to build beneath the cover up to a maximum pressure. A filter is disposed in the interior space to define a steeping chamber between the filter and the cover and is adapted to restrict the flow of fluid sufficiently to cause the steeping chamber to fill with fluid without exceeding the maximum pressure. Ingredients are disposed in the interior space for preparing a desired product.
Description
FIELD

This specification relates to capsules for preparing consumable products using capsule machines, and in particular to capsules adapted to provide improved conditions for preparing a steeped consumable product in a capsule machine.


BACKGROUND

The following background discussion is not an admission that anything discussed below is citable as prior art or common general knowledge. The documents listed below are incorporated herein in their entirety by this reference to them.


Single serve capsules adapted for use in machines to prepare a desired consumable product are becoming increasingly popular. Such capsules come in a variety of formats for producing consumable products such as coffee, tea or hot chocolate.


In North America, a leading provider of capsules and capsule machines is Keurig Green Mountain Inc. This company produces K-Cup™ capsules and Keurig™ capsule machines also known as brewers). K-Cup™ capsules have a first chamber defined by a paper filter that is loosely packed with ingredients (such as ground coffee) and a second chamber downstream of the first chamber that defines an empty space for receiving a prepared product that flows through the paper filter prior to dispensing into a cup.


A predetermined volume of heated water is injected by a Keurig™ machine into the first chamber of a K-cup™ coffee capsule at a predetermined flow rate. The heated water flows through the ingredients in the capsule and contacts the paper filter. The bottom portion of the paper filter quickly becomes saturated and allows the prepared product to flow through the filter at substantially the same flow rate as fluid enters the capsule. As a result, the fluid tends to continuously flow through the ingredients with less than optimum mixing and extraction. It has been found that ingredients in K-cup™ capsules used in Keurig™ machines are not optimally saturated other than ingredients disposed along the central fluid flow path of the capsule. Nonetheless, K-cup™ capsules remain a leading brand of capsules in the North American single serve coffee market.


The optimum conditions for preparing drip-style coffee differ from the optimum conditions for preparing other forms of consumable products. For example, certain consumable products, such as whole leaf tea products, benefit from soaking or steeping (the term steeping will be used hereafter) the precursor ingredients in a fluid, such as heated water, for a desired period of time prior to dispensing into a user's cup. Such products often also benefit from a mixing or turbulence of the precursor ingredients within the fluid during the steeping phase.


A problem with conventional capsules and capsule machines such as the K-cup™ capsules and Keurig™ machines is that their structure and operations are designed primarily for the purpose of preparing drip-style filtered coffee. This problem is exasperated by the desire to produce a prepared beverage in a relatively short time frame (60 seconds or less) thus requiring fluid to be injected into the machine at a relatively high flow rate.


This problem could be addressed by designing capsule machines that provide optimum conditions for preparing a steeped consumable product. This does not provide a solution for consumers who desire a shorter preparation time or who already own a conventional capsule machine and wish to avoid acquiring a new appliance however.


There is a need for a capsule that is adapted to provide improved conditions for preparing a steeped consumable product. There is also a need for such a capsule to be used with conventional capsule machines.


SUMMARY

In one aspect the invention provides a capsule, for use in a machine for preparing consumable products from capsules, said machine having an injection system that includes at least one injection nozzle for injecting heated fluid into said capsule at a predetermined flow rate, said capsule comprising:


a body defining an interior space with an opening;


a cover disposed over said opening, said cover being formed of a material that is resistant to tearing and adapted to shrink sufficiently around said at least one injection nozzle when said at least one injection nozzle pierces said cover and injects heated fluid into said capsule to create a seal that allows pressure to build within said interior space beneath said cover up to a maximum pressure;


a filter disposed in said interior space to define a steeping chamber between said filter and said cover, said filter being formed of one or more materials that are sufficiently phobic to said heated fluid to cause said steeping chamber to fill with fluid without exceeding said maximum pressure; and


ingredients disposed in said interior space for preparing a desired product.


In another aspect, the invention provides a capsule, for use in a machine for preparing consumable products from capsules, said capsule comprising:


a body defining an interior space with an opening;


a cover disposed over said opening;


a filter disposed in said interior space to define a chamber between said filter and said cover; and


ingredients disposed in said chamber for preparing a desired product, at least 50% of said ingredients having a particulate size greater than a #16 mesh.


Other aspects and features of the teachings disclosed herein will become apparent, to those ordinarily skilled in the art, upon review of the following description of the specific examples of the specification.





DRAWINGS

The drawings included herewith are for illustrating various examples of articles, methods, and apparatuses of the present specification and are not intended to limit the scope of what is taught in any way. For simplicity and clarity of illustration, where considered appropriate, reference numerals may be repeated among the drawings to indicate corresponding or analogous elements.



FIG. 1 is a sectional view of a capsule in accordance with one aspect of the present invention disposed within a schematic representation of a machine for preparing consumable products from capsules;



FIG. 2 is an enlarged sectional view of the capsule of FIG. 1 during use in the capsule machine;



FIG. 3 is a sectional view of a capsule in accordance with another aspect of the present invention;



FIGS. 4A-4H are schematic sectional views of the capsule and machine of FIG. 1 during consecutive stages of the process for preparing a consumable product.





DESCRIPTION OF VARIOUS EMBODIMENTS

Various apparatuses or methods will be described below to provide examples of the claimed invention. The claimed invention is not limited to apparatuses or methods having all of the features of any one apparatus or method described below or to features common to multiple or all of the apparatuses described below. The claimed invention may reside in a combination or sub-combination of the apparatus elements or method steps described below. It is possible that an apparatus or method described below is not an example of the claimed invention. The applicant(s), inventor(s) and/or owner(s) reserve all rights in any invention disclosed in an apparatus or method described below that is not claimed in this document and do not abandon, disclaim or dedicate to the public any such invention by its disclosure in this document.


A capsule in accordance with the present invention is shown generally at 10 in the Figures. Capsule 10 includes a body 12, filter 14, ingredients 16 and cover 18. Body 12 and cover 18 are each preferably formed of multilayered materials that include one or more barrier layers providing barriers against one or more environmental factors such as light, oxygen, and moisture. Capsule 10 may be sized to provide a single serving of a desired product or multiple servings.


Capsule 10 is sized and configured for use in a machine 20 that is adapted for preparing a product from capsule 10.


Machine 20 includes an injection system 22 for injecting a fluid, typically heated water, into the capsule 10 for mixing with ingredients 16. Injection system 22 may include at least one injection nozzle 22a disposed on machine 20 that is adapted to pierce cover 18 to inject fluid into capsule 10. In an alternative embodiment (not shown), injection system 22 may have at least one component disposed on capsule 10, such as on body 12 beneath cover 18, and adapted to pierce cover 18 and interact with other components of injection system 22 on machine 20 to inject fluid into capsule 10.


Machine also includes a dispensing system 24 for dispensing product from capsule 10 into a desired receptacle such as a bowl or cup. Dispensing system 24 may include a hollow probe 24a that is adapted to pierce capsule 10 to dispense a prepared product from capsule 10.


Body 12 of capsule 10 includes a sidewall 30 and an end wall 32 together defining an interior space 34. Interior space 34 preferably has a volume in the range of 30 cc to 100 cc for preparing a single serving of beverage and more preferably a volume in the range of 40 cc to 80 cc.


An opening 36 is defined at one end of body 12 and a flange 38 extends around the perimeter of opening 36 to receive cover 18 and to support capsule 10 within machine 20. Filter 14 may be secured to flange 38 or to an interior surface of capsule 10 (such as to sidewall 30 or the underside of cover 18).


In another embodiment (not shown), body 12 may be formed with no end wall 32 and no sidewall 30 or a partial sidewall 30. Flange 38 may still extend around the perimeter of opening 36 to receive cover 18 and to support capsule 10 within machine 20. Filter 14 may be secured to flange 38 or to partial sidewall 30 or underside of cover 18.


Cover 18 is disposed over opening 36 and secured to body 12 such as by sealing cover 18 directly to flange 38 or by sealing cover 18 to filter 14 which in turn is sealed to flange 38. Cover 18 may be transparent in order that ingredients 16 may be viewed through cover 18 prior to use of capsule 10 in machine 20.


Cover 18 is formed of a material that is resistant to tearing and adapted to shrink upon exposure to heat. Cover 18 is thus adapted to shrink around the opening formed in cover 18 by injection system 22 to form a sufficient seal to withstand the buildup in pressure within capsule 10 under normal conditions during use in machine 20. In other words, cover 18 is adapted to shrink sufficiently around the at least one injection nozzle when the at least one injection nozzle pierces the cover and injects heated fluid into the capsule to create a seal and allow the buildup in pressure within capsule up to a maximum pressure.


Preferably, cover 18 is formed of a multi-layered material having a minimum tensile strength of 3000 psi and a minimum elongation of 50%. Preferably cover 18 includes polymer materials, more preferably cover 18 comprises at least 50% polymer materials and most preferably cover 18 comprises at least 75% polymer materials.


Examples of suitable materials for cover 18 include polyethylene (PE), polyethylene terephthalate (PET) and polyamide PA6. A multi-layered material for cover 18 may include at least one layer formed of a continuous film of tear resistant and heat shrinkable material (laminated or extrusion coated) or a non-continuous film such as a non-woven polymer, mesh or perforated film. Examples of a multi-layered material for cover 18 include (from outside layer to inside layer): PET/aluminum foil/PE, PET/EVOH/PE, PET/metalized PET/PE or PET/PE. It has been found that formation of cover 18 from a multilayered PET/PE or PET/EVOH/PE material comprising at least 90% polymer materials provides preferred sealing performance around injection system 22.


A steeping chamber 40 is defined within interior space 34 of capsule 10 between cover 18 and filter 14. Steeping chamber 40 has a volume V1 that is adapted to contain a sufficient volume V2 of ingredients 16 to produce a desired consumable product using machine 20. Ingredients 16 that are disposed in steeping chamber 40, as described further below, are preferably selected for optimum extraction under the conditions within steeping chamber 40 during use of machine 20.


For the embodiment depicted in FIGS. 1 and 2, the volume V2 of ingredients 16 is no less than 50% of the volume V1 of steeping chamber 40, more preferably no less than 70% and most preferably no less than 90% so that ingredients are easily visible through a transparent cover 18.


Filter 14 has an average fluid flow rate F1 that is less than the average fluid flow rate F2 of injection system 22. Preferably, the average fluid flow rate F1 of filter 14 is between 50% and 90% of the average fluid flow rate F2 of injection system 22, more preferably between 55% and 80% and most preferably between 60% and 75%.


The average fluid flow rates F1 and F2 noted above are determined over the course of the product preparation process using machine 20 in accordance with the test procedure below. An empty capsule 10 containing no filter 14 and no ingredients 16 is disposed in machine 20 and machine 20 is activated to prepare a product of a selected size. The weight of the product prepared by the machine 20 is measured as well as the time required to prepare the product from the moment machine 20 is activated to the moment the flow of prepared product has stopped. The measured weight per unit of time is deemed to be the fluid flow rate F2 for injection system 22. The first capsule is removed and an empty capsule 10 with a filter 14 (but no ingredients 16) is then disposed in same machine 20 and machine 20 is activated to prepare a product of the same selected size. The weight of the product prepared by machine 20 is measured as well as the time required to prepare the product from the moment machine 20 is activated to the moment the flow of prepared product has stopped. The measured weight per unit of time is deemed to be the fluid flow rate F1 for filter 14.


Filter 14 may have a uniform fluid flow rate F1 over its entire surface area within interior space 34 or it may be adapted to provide zones 42 having different rates of fluid flow. Filter 14 may thus be adapted to provide one or more high flow zones 42a that allow a relatively higher rate of fluid flow as compared to the remainder of filter 14. Conversely, filter 14 may be adapted to provide one or more low flow zones 42b that allow a relatively low rate of fluid flow as compared to the remainder of filter 14. Zones 42 may also be disposed at desired locations L on filter 14 to optimize the performance of steeping chamber 40. For example, high flow zones 42a may be at locations L1 on filter 14 proximate to cover 18 to allow air to flow in the head space above the fluid to balance the pressure differential between steeping chamber 40 and the remainder of capsule 10. Low flow zones 42b may be at locations L2 along the sides of filter 14 to reduce the fluid flow along such side portions and thus encourage flow through the bottom portion of filter 14.


Filter 14 is also adapted to be phobic to the fluid being injected into capsule 10. In most instances, the fluid will comprise water (either heated or cooled) and a hydrophobic filter 14 is desired. Filter 14 may be formed of materials that are phobic to fluid such as polyolefins (eg, polyethylene, polypropylene) and mixtures of polyolefins with other polymers or filter 14 may be coated with materials that are phobic to fluid such as a polyethylene coating.


Filter 14 preferably has an air permeability of at least 400 L/s.m2, more preferably at least 1000 L/s.m2 and even more preferably at least 1800 L/s.m2 (all measurements based on ASTM Standard D737-96 “Standard Test Method for Air Permeability of Textile Fabrics”). By comparison, the conventional pleated paper filter for the Keurig K-cup™ capsule has a basis weight of 40 grams per square meter (gsm) and an air permeability of approximately 250 L/s. m2.


Preferably, filter 14 is formed of a non-woven fabric filtration material such as polyester, polyethylene or nylon non-woven fabric. The basis weight for filter 14 is in the range of 40 to 150 gsm and more preferably between 70 to 120 gsm.


Preferably, filter 14 is formed of a moldable non-woven filtration material that includes a plurality of multi-component fibers that are bound or interlocked by non-woven manufacturing techniques (such as spun bond techniques) to form a web having channels extending from one side of filter 14 to the other. The desired diameter for channels after forming is between 20 and 100 μm, more preferably between 40 to 80 μm. More details of a preferred filtration material for filter 14 are provided in co-pending patent application Ser. No. 14/074,024 which is incorporated in its entirety herein by reference.


Filter 14 may alternatively be formed of a polymer sheet, such as polyester or Nylon, which may be perforated or otherwise modified to define channels. The size and distribution of openings are optimized in a way that is resistant to water exiting.


Filter 14 may alternatively be formed from an ultra high molecular weight polyethylene (UHWMPE) which is also a filter material due to the cavities/pores formed during polymerization.


Filter 14 may alternatively be formed from modified filter paper with a phobic coating to achieve the fluid resistant property. Preferably, the coating is distributed on filter in a manner that creates high flow zones and/or low flow zones as described further below.


More details of the manner for securing filter 14 and cover 18 to flange 38 of body 12 are provided in co-pending patent application Ser. No. 13/600,582 which is incorporated in its entirety herein by reference.


Cover 18 and filter 14 may be adapted to be removed from body 12 for instance by separating an integral tab (not shown) defined in flange 38 and applying a peeling force. More details of capsules 10 having portions that are removable are provided in co-pending patent application Ser. No. 14/098,915 which is incorporated in its entirety herein by reference.


While filter 14 has an average fluid flow rate F1 over the course of the product preparation process in machine 20, the fluid flow rate may vary widely at different times during the process due to the fluid phobic properties of filter 14. At the beginning of the product preparation process for example, as steeping chamber 40 is filling with fluid, the phobic properties of filter 14 may result in little or no fluid flowing through filter 14. This results in an extended dwell time for ingredients 16 and fluid within steeping chamber 40. Once steeping chamber 40 is filled with fluid then the fluid flow rate of filter 14 may increase as fluid continues to flow into steeping chamber 40 through injection system 22 and as the surface tension of fluid is broken and fluid is forced to flow through filter 14. Certain machines 20 may further include a pulse cycle that varies the timing and/or amount of fluid that is injected into the capsule 10 using injection system 22.


The phobic properties of filter 14 are adapted to restrict the flow of fluid through capsule 10 by a sufficient amount within the operational constraints of machine 20 to optimize the extraction or infusion of ingredients 16 disposed within steeping chamber 40. As described further below, once steeping chamber 40 is filled with fluid, the pressure within steeping chamber 40 will increase as the fluid continues to flow into steeping chamber 40 through injection system 22. The increase in pressure within steeping chamber 40 is believed to further enhance the process of extraction or infusion of ingredients 16 disposed within steeping chamber 40. Also, extracts from ingredients 16 such as aroma and taste compounds, lipid and functional compounds may act to reduce the surface tension of fluid to further permit flow through filter 14.


A steeping chamber 40 having a greater volume V1 will take a greater period of time in a machine 20 to fill with fluid before pressure builds up within steeping chamber 40. A steeping chamber 40 having a lesser volume V1 will conversely take a lesser period of time to fill with fluid and thus will build up pressure sooner and to a greater extent as fluid continues to flow into steeping chamber 40. It has been found that a lesser volume V1 is preferred for optimum performance of steeping chamber 40.


Ingredients 16 that are disposed in steeping chamber 40 may include insoluble ingredients 16 such as tea leaves, coffee grounds, herbs, spices or other ingredients adapted for forming a consumable product by extraction or infusion. Additional ingredients 16 may be disposed either in steeping chamber 40 or elsewhere in interior space 34. Such additional ingredients 16 may include soluble ingredients 16 such as coffee, chocolate, soup stock, flavor additives or other ingredients in powdered, crystallized or other forms adapted for solubility or contained within a soluble film or pouch. Additional ingredients 16 may also include active ingredients (eg foaming agents), natural health additives, regulated drugs, alcohol or other soluble or insoluble ingredients.


One or more ingredients 16 may include sensory attributes that are desirable to convey to a consumer or end user prior to the preparation of the consumable product. For example, ingredients 16 may include soluble or insoluble ingredients having visual attributes that may be of interest to a consumer. Examples of ingredients 16 with visual attributes include whole tea leaves, florets, pieces of dried fruit, vegetables, herbs, nuts or beans, pieces of chocolate, spices (such as cloves or cinnamon sticks), natural health additives (eg gogi berries), dried pieces of meat (eg shrimp), tofu, vegetables or noodles for soup.


In a preferred embodiment, ingredients 16 include a subset of ingredients having irregular shapes and/or relatively large particulate sizes such as one or more of whole leaf teas, herbs, spices, fruits and flowers. Preferably ingredients 16 include a combination of larger particulate sizes and smaller particulate sizes. Ingredients having larger particulate sizes may include whole or substantially whole leaves or other desired portions of tea, herbs, spices, fruits and flowers. Ingredients having smaller particulate sizes may include cut, ground, crystallized or otherwise processed portions of such ingredients. Preferably, at least 50% of the ingredients comprise ingredients having a particulate size greater than a #16 mesh (1.18 mm). More preferably, at least 70% of the ingredients comprise ingredients having a particulate size greater than a #16 mesh.


In one embodiment, for single serve capsules 10 having a volume up to 100 cc, a preferred consumable product having improved sensory attributes is formed from 1.5 grams to 30 grams of ingredients 16 comprising one or more of whole leaf teas, herbs, spices, fruits or flowers as described above in which at least 50% of ingredients 16 have a particle size of at least 1.18 mm (mesh #16).


In other embodiments, multiple filters 14 may be disposed within interior space 34 of capsule 10. Such filters 14 may be disposed inside or outside of steeping chamber 40. Additional filters 14 may have different average fluid flow rates as well as different degrees of phobicity or non-phobicity to fluid.



FIG. 3 for example depicts a capsule 10 in accordance with an alternate embodiment of the invention. The same figure references are used to identify similar features to the capsule 10 for the embodiment described above.


Capsule 10 includes a steeping chamber 40 defined between cover 18 and filter 14a. Filter 14a has fluid phobic properties similar to those described in the embodiment above. It may be seen that steeping chamber 40 has a greater volume V1 than the volume V1 for the embodiment of capsule 10 described above. This allows a longer dwell time before the conditions within steeping chamber 40 cause fluid to flow through filter 14a.


Capsule 10 further includes a second filter 14b disposed in steeping chamber 40 above filter 14a. Second filter 14b defines a first ingredients chamber 44 that is disposed proximate to a transparent cover 18. Ingredients chamber 44 is adapted to contain a subset of ingredients 16a that have visual attributes that may be viewed through transparent cover 18. Additional ingredients 16b are disposed in steeping chamber 40 outside of first ingredients chamber 44 (these may include additional insoluble ingredients 16 that may have less desirable visual attributes). Additional ingredients 16c may also be disposed in interior space 34 outside of steeping chamber 40 (these may include soluble or active ingredients 16).


Referring to FIGS. 4A-4H, a capsule 10, in accordance with the first embodiment depicted in FIGS. 1 and 2, is shown during different stages of the process for preparing a consumable product from the capsule 10. FIG. 4A shows capsule 10 disposed in machine 20 prior to activation of the product preparation process. FIG. 4B shows an injection nozzle 22a for injection system 22 piercing cover 18 of capsule 10 and a dispensing nozzle 24a for dispensing system 24 piercing end wall 32 of capsule 10. FIG. 4C shows fluid (heated water) being injected into steeping chamber 40 of capsule 10. FIG. 4D shows fluid (heated water and extract from ingredients 16) collecting within steeping chamber 40 due to the phobic properties of filter 14. FIG. 4E shows steeping chamber 40 filled with fluid (heated water and extract from ingredients 16) and fluid (heated water and extract from ingredients 16) passing through filter 14 of capsule 10 for dispensing through dispensing system 24. It can be seen in FIG. 4E that cover 18 bulges upwardly away from steeping chamber 40 due to the higher pressure within steeping chamber 40 as fluid continues to enter steeping chamber 40 at a higher rate than fluid exits through filter 14. FIG. 4F shows the fluid level within steeping chamber 40 dropping as the flow rate of fluid entering steeping chamber 40 through injection system 22 subsides. FIG. 4G shows the fluid level within steeping chamber 40 continuing to drop as a blast of air is injected into steeping chamber 40 through injection system 22 to complete the product preparation process. FIG. 4H shows capsule 10 following completion of the product preparation process with little or no fluid remaining in capsule 10 and fully saturated ingredients 16 disposed in steeping chamber 40.


While the above description provides examples of one or more processes or apparatuses, it will be appreciated that other processes or apparatuses may be within the scope of the accompanying claims.

Claims
  • 1. A capsule, for use in a machine for preparing consumable products from capsules, said machine having an injection system that includes at least one injection nozzle for injecting heated fluid into said capsule at a predetermined flow rate, said capsule comprising: a body defining an interior space with an opening;a cover disposed over said opening, said cover being formed of a material that is heat shrinkable and resistant to tearing so as to shrink sufficiently around said at least one injection nozzle when said at least one injection nozzle pierces said cover and injects heated fluid into said capsule, to create a seal that allows pressure to build within said interior space beneath said cover up to a maximum pressure;a filter disposed in said interior space to define a steeping chamber between said filter and said cover, said filter being formed of one or more materials that are sufficiently phobic to said heated fluid to cause said steeping chamber to fill with fluid without exceeding said maximum pressure; andingredients disposed in said steeping chamber for preparing a desired product,wherein said filter is constructed and arranged to restrict a flow of the fluid through said filter to optimize extraction or infusion of said ingredients disposed within said steeping chamber.
  • 2. The capsule of claim 1, wherein said filter has an average fluid flow rate that is in the range of 50% to 90% of the average fluid flow rate for fluid being injected into said capsule.
  • 3. The capsule of claim 1 wherein said filter has an average fluid flow rate that is in the range of 60% to 80% of the average fluid flow rate for fluid being injected into said capsule.
  • 4. The capsule of claim 1 wherein said steeping chamber has a volume that is at least 90% filled by said ingredients.
  • 5. The capsule claim 1 wherein at least 50% of said ingredients disposed in said steeping chamber have a particulate size greater than a #16 mesh.
  • 6. The capsule of claim 1 wherein said ingredients are selected from tea, herbs, spices, fruits and flowers.
  • 7. The capsule of claim 1 wherein said cover has a minimum tensile strength of 3000 psi.
  • 8. The capsule of claim 1 wherein said cover has a minimum elongation of 50%.
  • 9. The capsule of claim 1 wherein said ingredients may be viewed through said cover prior to use of said capsule in said machine.
  • 10. The capsule of claim 1 wherein said filter includes one or more high flow zones that allow a higher rate of fluid flow compared to the remainder of said filter.
  • 11. The capsule of claim 1 wherein said filter includes one or more high flow zones at a location on said filter proximate to said cover.
  • 12. The capsule of claim 1 wherein said filter includes one or more low flow zones that allow a lower rate of fluid flow compared to the remainder of said filter.
  • 13. The capsule of claim 1 wherein said filter includes one or more low flow zones disposed along the sides of said filter to reduce the fluid flow along said sides.
  • 14. The capsule of claim 1 further comprising a second filter disposed in said steeping chamber.
  • 15. The capsule of claim 14 wherein said second filter defines a first ingredients chamber that is adapted to contain a subset of said ingredients.
  • 16. The capsule of claim 15 wherein said cover is transparent and wherein said first ingredients chamber is disposed proximate to said transparent cover.
PCT Information
Filing Document Filing Date Country Kind
PCT/CA2015/050214 3/20/2015 WO 00
Publishing Document Publishing Date Country Kind
WO2015/139140 9/24/2015 WO A
US Referenced Citations (242)
Number Name Date Kind
2113715 Wilcox Apr 1938 A
2987221 Milton Jun 1961 A
3110121 Corrinet Nov 1963 A
3282703 Broadhurst Nov 1966 A
3399806 Lucas Sep 1968 A
3713936 Ramsay Jan 1973 A
4101627 Menier Jul 1978 A
4131064 Ryan et al. Dec 1978 A
4220673 Strobel Sep 1980 A
4235160 Olney et al. Nov 1980 A
4306367 Otto Dec 1981 A
4440796 Lunder et al. Apr 1984 A
4471689 Piana Sep 1984 A
4518639 Phillips May 1985 A
4559729 White Dec 1985 A
4619830 Napier Oct 1986 A
4701365 Iwaski Oct 1987 A
4728425 Sandvig Mar 1988 A
4859337 Woltermann Aug 1989 A
4865737 McMichael Sep 1989 A
4867993 Nordskog Sep 1989 A
4981588 Poulallion Jan 1991 A
4983410 Dinos Jan 1991 A
4995310 van der Lijn et al. Feb 1991 A
4996066 Love et al. Feb 1991 A
5008013 Favre et al. Apr 1991 A
5076433 Howes Dec 1991 A
5298267 Gruenbacher Mar 1994 A
5331793 Pophal et al. Jul 1994 A
5390587 Wu Feb 1995 A
5447631 Mahlich Sep 1995 A
5456929 Mifune et al. Oct 1995 A
5496573 Tsuji et al. Mar 1996 A
5536290 Stark et al. Jul 1996 A
5575383 Seeley Nov 1996 A
5601716 Heinrich et al. Feb 1997 A
5605710 Prindonoff et al. Feb 1997 A
5633026 Gruenbacher May 1997 A
5738786 Winnington-Ingram Apr 1998 A
5806582 Howes Sep 1998 A
5840189 Sylvan et al. Nov 1998 A
5858437 Anson Jan 1999 A
5866185 Burkett Feb 1999 A
5871096 Yakich Feb 1999 A
5871644 Simon et al. Feb 1999 A
5882716 Munz-Schaerer et al. Mar 1999 A
5885314 Oussoren et al. Mar 1999 A
5895672 Cooper Apr 1999 A
5896686 Howes Apr 1999 A
5897899 Fond Apr 1999 A
5923242 Slagle et al. Jul 1999 A
5957279 Howes Sep 1999 A
5971195 Reidinger et al. Oct 1999 A
6025000 Fond et al. Feb 2000 A
6146270 Huard et al. Nov 2000 A
6189438 Bielfeldt et al. Feb 2001 B1
6220147 Priley Apr 2001 B1
6223937 Schmidt May 2001 B1
6440256 Gordon et al. Aug 2002 B1
6514555 Fayard et al. Feb 2003 B1
6548433 Gbur et al. Apr 2003 B1
6557597 Riesterer May 2003 B2
6561232 Frutin May 2003 B1
6589577 Lazaris et al. Jul 2003 B2
6607762 Lazaris et al. Aug 2003 B2
6622615 Heczko Sep 2003 B2
6644173 Lazaris et al. Nov 2003 B2
6645537 Sweeney et al. Nov 2003 B2
6658989 Sweeney et al. Dec 2003 B2
6720070 Hamaguchi et al. Apr 2004 B2
6758130 Sargent et al. Jul 2004 B2
6810788 Hale Nov 2004 B2
6841185 Sargent et al. Jan 2005 B2
6854378 Jarisch et al. Feb 2005 B2
6869627 Perkovic et al. Mar 2005 B2
6913777 Rebhorn et al. Jul 2005 B2
6959832 Sawada Nov 2005 B1
6992586 Rosenfeld Jan 2006 B2
7067038 Trokhan et al. Jun 2006 B2
7153530 Masek et al. Dec 2006 B2
7279188 Arrick et al. Oct 2007 B2
7311209 Bentz et al. Dec 2007 B2
7328651 Halliday et al. Feb 2008 B2
7387063 Vu et al. Jun 2008 B2
7412921 Hu et al. Aug 2008 B2
7490542 Macchi et al. Feb 2009 B2
7543527 Schmed Jun 2009 B2
7552672 Schmed Jun 2009 B2
7552673 Levin Jun 2009 B2
7624673 Zanetti Jun 2009 B2
7594470 Scarchilli et al. Sep 2009 B2
7640842 Bardazzi Jan 2010 B2
7681492 Suggi et al. Mar 2010 B2
7685930 Mandralis et al. Mar 2010 B2
7763300 Sargent et al. Jul 2010 B2
7798055 Mandralis et al. Sep 2010 B2
7854192 Denisart et al. Dec 2010 B2
7856920 Schmed et al. Dec 2010 B2
7856921 Arrick et al. Dec 2010 B2
7910145 Reati Mar 2011 B2
8062682 Mandralis et al. Nov 2011 B2
8225771 Andre Jul 2012 B2
8286547 Lassota Oct 2012 B1
8361527 Winkler et al. Jan 2013 B2
8409646 Yoakim et al. Apr 2013 B2
8425957 Steenhof Apr 2013 B2
8474368 Kilber et al. Jul 2013 B2
8475854 Skalski et al. Jul 2013 B2
8481097 Skalski et al. Jul 2013 B2
8573114 Huang et al. Nov 2013 B2
8591978 Skalski et al. Nov 2013 B2
8673379 Skalski et al. Mar 2014 B2
8740020 Marina et al. Jun 2014 B2
8834948 Estabrook et al. Sep 2014 B2
20020020659 Sweeney et al. Feb 2002 A1
20030005826 Sargent et al. Jan 2003 A1
20030039731 Dalton et al. Feb 2003 A1
20030082360 O'Donnell et al. May 2003 A1
20030087005 Baron May 2003 A1
20040045443 Lazaris Mar 2004 A1
20050016383 Kirschner et al. Jan 2005 A1
20050051478 Karanikos et al. Mar 2005 A1
20050287251 Lazaris et al. Dec 2005 A1
20060057373 Inagaki et al. Mar 2006 A1
20060236871 Ternite et al. Oct 2006 A1
20060246187 Egolf et al. Nov 2006 A1
20070144356 Rivera Jun 2007 A1
20070148290 Ternite Jun 2007 A1
20070275125 Catani Nov 2007 A1
20080015098 Littlejohn et al. Jan 2008 A1
20080142115 Vogt et al. Jun 2008 A1
20080156196 Doglioni et al. Jul 2008 A1
20080202075 Kronawittleithner et al. Aug 2008 A1
20080245236 Ternite et al. Oct 2008 A1
20090110775 Rijskamp et al. Apr 2009 A1
20090133584 De Graaff et al. May 2009 A1
20090165228 Kilkenny Jul 2009 A1
20090175986 Doglioni Majer Jul 2009 A1
20090186141 Almblad et al. Jul 2009 A1
20090206084 Woolf et al. Aug 2009 A1
20090211458 Denisart et al. Aug 2009 A1
20090260690 Bell Oct 2009 A1
20090311389 Zoss et al. Dec 2009 A1
20090324791 Ohresser et al. Dec 2009 A1
20100003379 Zoss et al. Jan 2010 A1
20100028495 Novak et al. Feb 2010 A1
20100116772 Teys May 2010 A1
20100215808 Versini Aug 2010 A1
20100239733 Yoakim et al. Sep 2010 A1
20100303964 Beaulieu et al. Dec 2010 A1
20110003040 Graf et al. Jan 2011 A1
20110033580 Bieshuevel et al. Feb 2011 A1
20110045144 Boussemart et al. Feb 2011 A1
20110076361 Peterson et al. Mar 2011 A1
20110183048 Noble et al. Jul 2011 A1
20110185911 Rapparini Aug 2011 A1
20110247975 Rapparini Oct 2011 A1
20120006205 Vanni Jan 2012 A1
20120024160 Van et al. Feb 2012 A1
20120052163 Doleac et al. Mar 2012 A1
20120058226 Winkler et al. Mar 2012 A1
20120070542 Camera et al. Mar 2012 A1
20120070551 Mahlich Mar 2012 A1
20120097602 Tedford Apr 2012 A1
20120121764 Lai et al. May 2012 A1
20120171334 Yoakim Jul 2012 A1
20120174794 Fraij Jul 2012 A1
20120180670 Yoakim Jul 2012 A1
20120180671 Baudet Jul 2012 A1
20120183649 Burkhalter Jul 2012 A1
20120186457 Ozanne Jul 2012 A1
20120196008 York Aug 2012 A1
20120199007 Larzul Aug 2012 A1
20120199010 Mariller Aug 2012 A1
20120199011 Cheng Aug 2012 A1
20120201933 Dran et al. Aug 2012 A1
20120207893 Kreuger Aug 2012 A1
20120207894 Webster Aug 2012 A1
20120210876 Glucksman Aug 2012 A1
20120210878 Mariller Aug 2012 A1
20120210879 Mariller Aug 2012 A1
20120231123 Kamerbeek Sep 2012 A1
20120231124 Kamerbeek Sep 2012 A1
20120231126 Lo Faro Sep 2012 A1
20120231133 Kamerbeek Sep 2012 A1
20120251668 Wong Oct 2012 A1
20120251669 Kamerbeek Oct 2012 A1
20120251670 Kamerbeek Oct 2012 A1
20120251671 Kamerbeek Oct 2012 A1
20120251692 Kamerbeek Oct 2012 A1
20120251693 Kamerbeek Oct 2012 A1
20120251694 Kamerbeek Oct 2012 A1
20120258204 Tsuji Oct 2012 A1
20120258210 Wong Oct 2012 A1
20120258219 Wong Oct 2012 A1
20120258221 Wong Oct 2012 A1
20120260806 Rolfes Oct 2012 A1
20120263829 Kamerbeek Oct 2012 A1
20120263830 Kamerbeek Oct 2012 A1
20120263833 Wong Oct 2012 A1
20120266755 Baudet Oct 2012 A1
20120269933 Rapparini Oct 2012 A1
20120272830 Gugerli Nov 2012 A1
20120276252 Bunke Nov 2012 A1
20120276255 Verbeek Nov 2012 A1
20120297987 Lee Nov 2012 A1
20120301581 Abegglen Nov 2012 A1
20120307024 Howes Dec 2012 A1
20120308688 Peterson Dec 2012 A1
20120312174 Lambert Dec 2012 A1
20120321755 Macaulay Dec 2012 A1
20120321756 Estabrook et al. Dec 2012 A1
20120328739 Nocera Dec 2012 A1
20120328740 Nocera Dec 2012 A1
20120328744 Nocera Dec 2012 A1
20130004629 Clark Jan 2013 A1
20130004637 Gugerli Jan 2013 A1
20130008316 Hoeglauer Jan 2013 A1
20130011521 Weijers et al. Jan 2013 A1
20130017303 Vu Jan 2013 A1
20130025466 Fu Jan 2013 A1
20130032034 Jarisch Feb 2013 A1
20130047863 Larzul Feb 2013 A1
20130059039 Trombetta Mar 2013 A1
20130059903 Deuber Mar 2013 A1
20130068109 Pribus et al. Mar 2013 A1
20130084368 Linck et al. Apr 2013 A1
20130095219 de Graaff et al. Apr 2013 A1
20130115342 Van et al. May 2013 A1
20130122153 Ferrier et al. May 2013 A1
20130122167 Winkler et al. May 2013 A1
20130142931 Fin et al. Jun 2013 A1
20130156899 Quinn Jun 2013 A1
20130259982 Abegglen et al. Oct 2013 A1
20130340626 Oh Dec 2013 A1
20130344205 Oh Dec 2013 A1
20140013958 Krasne et al. Jan 2014 A1
20140037802 Cardoso Feb 2014 A1
20140099388 Wang et al. Apr 2014 A1
20140124435 Jackson May 2014 A1
20140220192 Deeb Aug 2014 A1
20150050391 Rapparini Feb 2015 A1
Foreign Referenced Citations (45)
Number Date Country
2012891 Sep 1991 CA
2276927 Jan 2000 CA
2516417 Sep 2004 CA
2517840 Nov 2004 CA
2689804 Mar 2008 CA
2686347 Dec 2008 CA
2745239 Jun 2010 CA
2807489 Feb 2012 CA
2824199 Aug 2012 CA
2831304 Oct 2012 CA
2759782 Nov 2012 CA
2839293 Dec 2012 CA
2810236 Mar 2013 CA
0047169 Mar 1982 EP
0145499 Jun 1985 EP
0432126 Jun 1991 EP
0 615 921 Sep 1994 EP
1208782 Aug 2004 EP
1593329 Nov 2005 EP
1859683 Nov 2007 EP
2230195 Sep 2010 EP
2345351 Jul 2011 EP
2409608 Jan 2012 EP
2930522 Oct 2009 FR
803486 Oct 1958 GB
962038 Jun 1964 GB
2074838 Nov 1981 GB
662737 Mar 1994 JP
11171249 Jun 1999 JP
9212660 Aug 1992 WO
0145616 Jun 2001 WO
03082065 Oct 2003 WO
2004083071 Sep 2004 WO
2004112556 Dec 2004 WO
2009114119 Sep 2009 WO
2010013146 Feb 2010 WO
2010066705 Jun 2010 WO
2010085824 Aug 2010 WO
2011095518 Aug 2010 WO
201006516 Sep 2010 WO
2010137956 Dec 2010 WO
2012031106 Mar 2012 WO
2012069505 May 2012 WO
2014037339 Mar 2014 WO
2014056862 Apr 2014 WO
Non-Patent Literature Citations (2)
Entry
Kalpakjian, Schmid, Polymer Properties, Table 10.1, Manfacturing Processes for Engineering Materials 5th ed., Pearson Education 2008, [on line]. Downloaded from the Internet: URL:<https://www.slideshare.net/abhalim77/ch10-53447436>.
International Search Report in PCT/CA2015/050214 dated Jun. 17, 2015.
Related Publications (1)
Number Date Country
20180118450 A1 May 2018 US
Provisional Applications (1)
Number Date Country
61968843 Mar 2014 US